JJSF Stock Analysis: J & J Snack Foods | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 1.461m USD | 12M Return: -10.1% | US4660321096 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 16.2M
EPS Trend: -67.1%
Qual. Beats: 0
Rev. Trend: -28.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
J&J Snack Foods Corp. (JJSF) is a U.S.-based manufacturer, marketer, and distributor of snack foods and frozen beverages, operating across three segments: Food Service, Retail Supermarkets, and Frozen Beverages. Its portfolio spans soft pretzels (SUPERPRETZEL, NEW YORK PRETZEL, BAVARIAN BAKERY), frozen novelties (ICEE, DIPPINDOTS, LUIGIS, WHOLE FRUIT), churros, handheld items, bakery products (MRS. GOODCOOKIE, READI-BAKE, MARY BS), funnel cakes, and frozen beverage brands (SLUSH PUPPIE, ARCTIC BLAST, PARROT ICE), with significant private-label exposure.
The company sells through food brokers, independent distributors, and a direct sales force, serving a diverse customer base that includes chain restaurants, stadiums and arenas, theme parks, convenience stores, movie theatres, schools, warehouse clubs, and retailers in the United States, Mexico, and Canada. It also sells dispensing machines and parts to other food and beverage operators, a recurring-revenue component typical of frozen-beverage suppliers.
Founded in 1971 and headquartered in Mount Laurel, New Jersey, JJSF has been publicly traded since its 1990 IPO and is classified within the Consumer Staples sector (Packaged Foods & Meats), a segment generally characterized by stable demand and brand-driven product portfolios.
- Food service sales rebound as stadium and restaurant traffic recovers
- Input cost inflation squeezes gross margins across snack portfolio
- Dippin Dots acquisition expands frozen novelty and retail footprint
| Net Income: 49.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.08 > 1.0 |
| NWC/Revenue: 17.38% < 20% (prev 17.73%; Δ -0.35% < -1%) |
| CFO/TA 0.12 > 3% & CFO 166.9m > Net Income 49.3m |
| Net Debt (292.7m) to EBITDA (139.2m): 2.10 < 3 |
| Current Ratio: 2.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.7m) vs 12m ago -4.13% < -2% |
| Gross Margin: 31.07% > 18% (prev 29.70%; Δ 1.37% > 0.5%) |
| Asset Turnover: 110.1% > 50% (prev 113.1%; Δ -3.04% > 0%) |
| Interest Coverage Ratio: 28.83 > 6 (EBIT TTM 62.3m / Interest Expense TTM 2.16m) |
| A: 0.20 (Total Current Assets 462.3m - Total Current Liabilities 197.3m) / Total Assets 1.36b |
| B: 0.61 (Retained Earnings 833.0m / Total Assets 1.36b) |
| C: 0.04 (EBIT TTM 62.3m / Avg Total Assets 1.38b) |
| D: 1.92 (Book Value of Equity 892.1m / Total Liabilities 463.8m) |
| Altman-Z'' = 5.61 = AAA |
| DSRI: 1.07 (Receivables 210.5m/206.0m, Revenue 1.52b/1.60b) |
| GMI: 0.96 (GM 29.70% / 31.07%) |
| AQI: 1.02 (AQ_t 0.26 / AQ_t-1 0.26) |
| SGI: 0.95 (Revenue 1.52b / 1.60b) |
| TATA: -0.09 (NI 49.3m - CFO 166.9m) / TA 1.36b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of October 12, 2026, the stock is trading at USD 81.13 with a total of 233,394 shares traded. Over the past week, the price has changed by +3.68%, over one month by -0.41%, over three months by +8.50% and over the past year by -10.13%.
Current recommended Stop Loss: 78.30 (which is 3.5% or 1.4 ATR below the current price).
J & J Snack Foods has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy JJSF.
- StrongBuy: 3
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 110.5 | 36.2% |
P/E Trailing = 30.3062
P/E Forward = 23.753
P/S = 0.958
P/B = 1.632
P/EG = 5.1232
Revenue TTM = 1.52b USD
EBIT TTM = 62.3m USD
EBITDA TTM = 139.2m USD
Long Term Debt = 28.0m USD (from longTermDebt, last quarter)
Short Term Debt = 24.3m USD (from shortTermDebt, last quarter)
Debt = 355.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 163.9m
Net Debt = 292.7m USD (calculated: Debt 355.8m - CCE 63.1m)
Enterprise Value = 1.75b USD (1.46b + Debt 355.8m - CCE 63.1m)
Interest Coverage Ratio = 28.83 (Ebit TTM 62.3m / Interest Expense TTM 2.16m)
EV/FCF = 19.06x (Enterprise Value 1.75b / FCF TTM 92.0m)
FCF Yield = 5.25% (FCF TTM 92.0m / Enterprise Value 1.75b)
FCF Margin = 6.03% (FCF TTM 92.0m / Revenue TTM 1.52b)
Net Margin = 3.23% (Net Income TTM 49.3m / Revenue TTM 1.52b)
Gross Margin = 31.07% ((Revenue TTM 1.52b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Gross Margin QoQ = 35.45% (prev 28.39%)
Tobins Q-Ratio = 1.29 (Enterprise Value 1.75b / Total Assets 1.36b)
Interest Expense / Debt = 0.61% (Interest Expense 2.16m / Debt 355.8m)
Taxrate = 19.87% (12.2m / 61.5m)
NOPAT = 49.9m (EBIT 62.3m * (1 - 19.87%))
Current Ratio = 2.34 (Total Current Assets 462.3m / Total Current Liabilities 197.3m)
Debt / Equity = 0.40 (Debt 355.8m / totalStockholderEquity, last quarter 892.1m)
Debt / EBITDA = 2.10 (Net Debt 292.7m / EBITDA 139.2m)
Debt / FCF = 3.18 (Net Debt 292.7m / FCF TTM 92.0m)
Total Stockholder Equity = 912.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.56% (Net Income 49.3m / Total Assets 1.36b)
RoE = 5.40% (Net Income TTM 49.3m / Total Stockholder Equity 912.9m)
RoCE = 6.62% (EBIT 62.3m / Capital Employed (Equity 912.9m + L.T.Debt 28.0m))
RoIC = 4.46% (NOPAT 49.9m / Invested Capital 1.12b)
WACC = 4.56% (E(1.46b)/V(1.82b) * Re(5.55%) + D(355.8m)/V(1.82b) * Rd(0.61%) * (1-Tc(0.20)))
Discount Rate = 5.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.94 | Cagr: -1.55%
[DCF] Terminal Value 77.97% ; FCFF base≈81.8m ; Y1≈93.8m ; Y5≈138.0m
[DCF] Fair Price = 95.53 (EV 2.08b - Net Debt 292.7m = Equity 1.78b / Shares 18.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -67.10 | EPS CAGR: -5.05% | SUE: 0.63 | # QB: 0
Revenue Correlation: -28.05 | Revenue CAGR: -0.42% | SUE: -0.35 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-09-30): EPS=3.99 | Chg30d=+1.96% | Revisions=-25% | GrowthEPS=-6.6% | GrowthRev=-4.5%
EPS next Year (2027-09-30): EPS=4.32 | Chg30d=-0.31% | Revisions=+0% | GrowthEPS=+8.4% | GrowthRev=+2.0%
[Analyst] Revisions Ratio: -17% (up=1, down=2)